[ad_1]
Vaccination with coronavir could begin in the United States before mid-December, he said. Moncef slaoui, a senior leader in a government-organized vaccination campaign.
Our plan is to deliver the vaccine to the vaccination sites within 24 hours after authorization, that is, the vaccination can begin on December 11 or 12.
Moncef Slaoui said on US news television CNN.
Pfizer’s New York-based company and its German partner, BioNTech, filed an application for authorization with the US Food and Drug Administration (FDA) on Friday. According to the New York Times, the FDA plans to study the appendix for three weeks, after which it will be examined by independent experts, and its meeting is scheduled for December 10. Pfizer announced Wednesday that it has completed the final phase of clinical testing of its 95 percent efficient ribonucleic acid messenger-based vaccine and expects to produce at least 50 million doses of vaccine this year and 1.3 billion doses in 2021.
In the United States, 12,102,101 confirmed infections, 255,953 deaths and 4,529,700 recovered were recorded on Sunday night, according to a summary from Johns Hopkins University in Baltimore.
Featured image: CHANDAN KHANNA / AFP
[ad_2]
